Lead party: European Investment Bank (EIB) (lead investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: Cape Bio Pharms
Transaction type: Debt Financing · Asset class: Venture Capital · Strategy: Direct Lending · Instrument: Term Loan · Deal amount: US$40.7m
Lead investor/buyer: European Investment Bank (EIB) · Investors/buyers: European Investment Bank (EIB)
Legal advisers: not identified in the source record.
Source: announced 18 December 2020. Original announcement: businessinsider.co.za.


